Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02462252
Title Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors BioLineRx, Ltd.
Indications

myelodysplastic syndrome

Therapies

anti-thymocyte globulin + BKT140 + Cyclosporine + Methylprednisolone

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.